- cln1 cln2 cln3 Mutants
- cln1∆ cln2∆ cln3∆
- cln1∆ cln2∆ cln3∆ GAL-CLN2
- cln1∆ cln2∆ cln3∆ GAL-CLN3
- cln1∆ cln2∆ cln3∆ sic1∆
- cln1∆ cln2∆ cln3∆ cdh1∆
- cln1∆ cln2∆ cln3∆ multi-copy CLB5
- cln1∆ cln2∆ cln3∆ GAL-CLB5
- cln1∆ cln2∆ cln3∆ multicopy BCK2
- cln1∆ cln2∆ cln3∆ GAL-CLB2
- cln1∆ cln2∆ cln3∆ apc-ts
cln1∆ cln2∆ cln3∆ multi-copy CLB5
debug: ,
test user =
test db =
Simulation:
Change of parameters: ksn2'= ksn2"=0, Dn3=0, ksb5'=0.0016, ksb5"=0.01 (=2 copies).
Length of G1 phase: 40.6 min.
Mass at division: 10.68
Experiments:
Epstein, C.B. and Cross, F.R. (1992). CLB5: a novel B cyclin from budding yeast with a role in S phase. Genes Dev. 6:1695-1706.
[Abstract] [Article]
[Abstract] [Article]
Experimental results: Viable. Fig. 1, a low copy number (CEN) plasmid carrying the CLB5 gene can suppress the lethality of triple-cln deletion.
Comments:
webmaster